Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4641 studies found for:    "Depressive Disorder" [DISEASE]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
Condition: Depressive Disorder
Intervention: Drug: Duloxetine Hydrochloride
2 Completed Major Depressive Disorder Study In Adults
Condition: Major Depressive Disorder
Intervention: Drug: paroxetine CR
3 Terminated Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: ABT-436;   Drug: Escitalopram;   Drug: Placebo
4 Completed Safety Study of F2695 SR in Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: F2695 SR
5 Completed
Has Results
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Vilazodone;   Drug: Placebo to citalopram;   Drug: Placebo to vilazodone;   Drug: Citalopram
6 Completed
Has Results
Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Dose-matched placebo;   Drug: Vilazodone
7 Completed Safety and Efficacy of Vilazodone in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Placebo;   Drug: Vilazodone
8 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
9 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
10 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
11 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release 10mg;   Drug: Desvenlafaxine Succinate Sustained-Release 50 mg;   Drug: placebo
12 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
13 Completed
Has Results
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine succinate sustained release 50 mg;   Drug: Desvenlafaxine succinate sustained release 25 mg;   Drug: Placebo
14 Completed Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: cariprazine;   Drug: placebo
15 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release (DVS SR);   Drug: placebo
16 Completed Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Device: transcranial direct current stimulation;   Drug: Sertraline;   Other: double placebo
17 Completed Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: DVS-233 SR
18 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: desvenlafaxine succinate sustained release;   Genetic: Genotyping
19 Completed Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Diluent / Insulin;   Drug: Insulin / Diluent
20 Completed A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: GSK561679;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.